Amlodipine showed anti-atherosclerotic properties in the CAMELOT trial, with significantly less atherosclerosis progression vs placebo by IVUS. Its anti-atherogenic effects may be partially independent of blood pressure lowering.
Research summaries are AI-generated from open-access peer-reviewed literature (PubMed Central, Cochrane, AHA/ACC). Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.